KURA
Kura Oncology, Inc.
+0.75 (+6.70%)11.95USD777K成交股數1.1B市值–本益比(近四季)13.8股價營收比+36.5%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 20.9M+37% | 18.3M+29% | 17.3M | 20.8M | 15.3M | 14.1M | – | – | – | – | – | – |
| 營業成本 | 243K | 262K | – | – | – | – | – | – | – | – | – | – |
| 毛利 | 20.6M | 18.0M | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | 98.8% | 98.6% | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 61.9M | 65.3M | 64.4M | 67.9M | 62.8M | 56.0M | 41.7M | 39.7M | 36.3M | 32.5M | 29.3M | 28.2M |
| 銷售管理費用 | 31.8M | 31.6M | 39.1M | 32.8M | 25.2M | 22.8M | 18.2M | 16.7M | 18.2M | 14.2M | 13.1M | 11.8M |
| 營業利益 | −73.0M+0% | −78.8M+22% | −86.3M+44% | −80.0M+42% | −72.7M+33% | −64.7M | −59.9M | −56.4M | −54.5M | – | – | – |
| 營業利益率 | -349.8% | -431.5% | -497.6% | -385.5% | -475.3% | -458.6% | – | – | – | – | – | – |
| 稅後淨利 | −68.3M+3% | −73.3M+28% | −81.0M+49% | −74.1M+46% | −66.1M+34% | −57.4M+34% | −54.4M+41% | −50.8M+37% | −49.5M | −42.8M | −38.6M | −37.2M |
| 淨利率 | -327.3% | -401.5% | -467.2% | -357.2% | -432.5% | -407.1% | – | – | – | – | – | – |
| 稀釋 EPS | -0.77+3% | -0.83+26% | -0.92+46% | -0.85+44% | -0.75+27% | -0.66+20% | -0.63+26% | -0.59+11% | -0.59 | -0.55 | -0.50 | -0.53 |
| 稀釋股數 | 88.9M | 88.6M | 87.7M | 87.6M | 87.6M | 87.4M | 87.0M | 86.6M | 83.9M | 73.2M | 77.2M | 69.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 70.2M | 39.1M | 149M | 95.3M | 81.9M | 51.3M | 49.5M | 45.2M | 41.5M | 37.3M | 28.7M | 49.1M |
| 應收帳款 | 9.4M | 9.3M | 8.8M | 35.9M | 4.6M | 48.7M | – | – | – | – | – | – |
| 存貨 | 2.5M | 843K | 413K | – | – | – | – | – | – | – | – | – |
| 總資產 | 588M | 653M | 738M | 649M | 682M | 744M | 479M | 515M | 554M | 449M | 474M | 495M |
| 有息負債 | 5.6M | 9.7M | 9.7M | 5.3M | 6.5M | 7.7M | 7.8M | 8.6M | 9.4M | 9.3M | 9.3M | 9.2M |
| 總負債 | 539M | 545M | 564M | 407M | 377M | 379M | 55.1M | 49.0M | 48.8M | 51.7M | 43.8M | 35.1M |
| 股東權益 | 48.4M | 108M | 174M | 243M | 305M | 364M | 424M | 466M | 505M | 397M | 430M | 460M |
| 負債比 | 91.8% | 83.5% | 76.4% | 62.7% | 55.2% | 51.0% | 11.5% | 9.5% | 8.8% | 11.5% | 9.3% | 7.1% |
| 淨現金(現金 − 有息負債) | 64.7M | 29.3M | 139M | 90.0M | 75.4M | 43.6M | 41.7M | 36.6M | 32.1M | 28.0M | 19.5M | 39.9M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −85.9M+19% | – | – | – | −71.9M | – | – | −48.8M | – | – | – |
| 資本支出 | – | 128K | – | – | – | 292K | – | – | 84K | – | – | – |
| 自由現金流 | – | −86.0M+19% | – | – | – | −72.2M | – | – | −48.9M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -470.7% | – | – | – | -511.9% | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 133M
| Collaboration Revenue | 65.4M | 49.2% | +21.3% |
|---|---|---|---|
| License And Collaboration Revenue | 65.4M | 49.2% | +21.3% |
| 產品 | 2.1M | 1.6% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 67.5M | +25.2% | −279M | -412.9% | -3.18 | −70.7M |
| FY2024 | 53.9M | – | −174M | -322.9% | -2.02 | 134M |
| FY2023 | 0.00 | – | −153M | –% | -2.08 | −125M |
| FY2022 | – | – | −136M | –% | -2.03 | −111M |
| FY2021 | – | – | −130M | –% | -1.97 | −106M |
| FY2020 | – | – | −89.6M | –% | -1.69 | −72.0M |
| FY2019 | – | – | −63.1M | –% | -1.51 | – |
| FY2018 | – | – | −60.4M | –% | -1.72 | – |